LAMIN A AND C (A/C) are type V intermediate filaments encoded by the LMNA gene that form the nuclear lamina (17) . The functions of lamin A/C are to support the inner nuclear envelope and to participate in DNA repair, signal transduction, mesenchymal stem cell differentiation, mitosis, and apoptosis (9, 17, 24) . LMNA mutations ("laminopathies") lead to a reduction in lamin A/C expression and diverse phenotypes such as familial cardiomyopathy and the Hutchinson-Gilford progeria-accelerated aging syndrome (5, 10, 33) . Normal aging is associated with a reduction in lamin A/C expression in mouse osteoblasts and human dermal fibroblasts (9, 30) . To date, the effect of normal aging on lamin A/C expression in cardiomyocytes remains unknown.
Age-related changes in lamin A/C expression in cardiomyocytes may be associated with the downstream changes in myocardial function and structure seen in aging hearts. This is suggested by observations of marked myocardial abnormalities in LMNA mutation carriers and in lamin A/C-deficient mice (26, 35) . We hypothesized that normal aging is associated with a reduction in lamin A/C expression in cardiomyocytes. We used lamin B1 expression (a nondevelopmentally regulated protein from the same family found in all nucleated cells independent of aging) as a control. Our primary objective was to compare the expression of lamin A/C in cardiomyocyte nuclei of old versus young mice using a well-validated mouse model of aging (13, 19, 20) .
MATERIALS AND METHODS
Animal tissue preparation. C57BL/6J mice (Jackson, Bar Harbour, ME) were housed in a limited access room restricted to aging mice (12-h:12-h light-dark cycle) as previously described (9) . All animal manipulations adhered to the Canadian Council on Animal Care Standards, and all protocols were approved by the McGill University and Lady Davis Institute Animal Care Utilization Committees. The colony was free of any parasitic, bacterial, or viral pathogens as determined by a sentinel program. With the use of CO2, animals were euthanized at 4 (n ϭ 5) and 24 mo of age (n ϭ 5). Hearts were dissected under sterile conditions, rinsed in 0.01 M PBS, blotted dry, and weighed. Heart pieces were frozen at Ϫ80°C for further protein expression analyses. Tissue was also fixed in 10% formaldehyde for histological analysis. Several sections of heart (4 to 5 m thick) were prepared and stained with hematoxylin and eosin and visualized by light microscope.
Echocardiography. Two-dimensional/M-mode echocardiography was performed in young (4 mo) and old (20 mo) C57Bl/6J male mice anesthetized with isoflurane. Mice were placed in an induction chamber, anesthetized in 2% isoflurane mixed with air, and then maintained in 0.5-0.7% isoflurane. After the removal of the thoracic fur, mice were placed in a left cubital position. Echocardiographic parasternal short-axis views at the midventricular level were acquired using a i13L transducer and a digital ultrasound system (Vivid 7, GE Medical Systems) at a 1 cm depth and 100 frames/s. Measurements were performed off-line with the use of a customized version of the EchoPac Software (GE Medical Systems). End-diastolic and endsystolic dimensions of the left ventricular (LV) cavity as well as anterior and posterior thickness of the LV wall were measured in M-mode tracings according to the leading-edge method (27) . Measurements were averaged from three consecutive beats of three image acquisitions. Fractional shortening, relative wall thickness, and LV mass were derived as described previously (32, 34) .
Quantification of lamin A/C and B1 expression by immunohistochemistry. After dissection and fixation, young and old heart samples were embedded in low-melting point paraffin in a Shandon Citadel 2000 automatic tissue processor (Shandon Scientific, Runcorn, UK). Coronal and transverse sections (4 mm) were mounted on silanecoated glass slides (Fischer Scientific, Springfield, NJ). Paraffin was removed with three washes of xylene and rehydrated with washes of graded ethanol (80%-50%-30%) and PBS. Nonspecific binding was blocked by an addition of goat serum for 1 h. Sections were then incubated with mouse monoclonal IgM lamin A/C antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for either 4 h at room temperature or 8 -24 h at 4°C. Sections incubated with mouse monoclonal IgG lamin B1 antibody (Santa Cruz Biotechnology) were used as controls. After sections were washed with PBS, hydrogen peroxidecomplexed rabbit anti-mouse IgG was added to the sections at room temperature for 30 min, followed by a 30-min incubation with 0.6% hydrogen peroxide Ϯ chromogen. Immunohistochemical staining was performed using the human avidin-biotin complex staining system (Santa Cruz Biotechnology). Lamin-positive cells showed a brown nucleus with punctate brown staining from the peroxidase-labeled antibody and blue counterstaining from the hematoxylin. Lamin A/C expression was calculated as the number of cardiomyocyte nuclei positively stained for lamin A/C (brown-stained nuclei) divided by the total number of cardiomyocyte nuclei (brown-and blue-stained nuclei) in each of 10 randomly chosen high power fields (HPF).
Quantification of lamin A/C by immunofluorescence. Heart sections were treated as described for immunohistochemistry, omitting the final step involving treatment of cells with hydrogen peroxide. After fixation in 4% paraformaldehyde, sections were washed with PBS and then incubated in PBS with 10% blocking serum for 20 min to suppress nonspecific binding of IgG. Sections were incubated with mouse monoclonal IgM lamin A/C antibody (Santa Cruz Biotechnology) with 1.5% blocking serum overnight at 4°C and then incubated with fluorescein-conjugated secondary antibody (FITC, Santa Cruz) diluted to 2 g/ml in PBS with 1.5% blocking serum for 45 min. Nuclei were counterstained using propidium iodine (2 g/ml). Control slides were incubated with rabbit IgG according to the manufacturer's instructions, and triplicate tests and control slides were included in immunodetection. Lamin A/C-positive cells showed intense nuclear green fluorescence, whereas negative controls showed only faint nuclear or cytoplasmic fluorescence. The number of positive cardiomyocyte nuclei divided by the total number of cardiomyocyte nuclei in each field was calculated as described for immunohistochemistry.
Quantification of lamin A/C and B1 expression by Western blot analysis. Nuclear extracts were obtained after suspending the heart pieces in two volumes of buffer containing 10 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail diluted according to the manufacturer's instruction (Complete protease inhibitor, Boehringer-Mannheim, Laval, QC, Canada). The homogenate was clarified by centrifugation at 25,000 g for 20 min at 4°C, and the nuclear pellet was resuspended in 20 mM HEPES (pH 7.9), 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl 2, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 0.5 mM dithiothreitol. Following a further 20-min centrifugation at 25,000 g, nuclear extracts (supernatant) were dialyzed for 5 h against 20 mM HEPES (pH 7.9), 20% glycerol, 0.1 M KCl, 0.2 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 0.5 mM dithiothreitol. Protein content was determined with a protein assay kit (Bio-Rad, Mississauga, ON, Canada), and samples were then aliquoted and stored at Ϫ80°C. For Western blot analyses, nuclear extracts were resuspended in SDS electrophoresis buffer (Bio-Rad, Hercules, CA), proteins were separated on SDSpolyacrylamide gels, and the proteins were electrotransfered to Immobilon-P polyvinylidene difluoride membranes. After being blocked with PBS containing 0.1% Tween 20 and 10% nonfat dry milk, membranes were incubated overnight at 4°C using a monoclonal antibody directed against lamin A/C and a second monoclonal antibody against lamin B1 (Santa Cruz). Specific staining was revealed after washing, and incubating with horseradish peroxidase-conjugated IgG rabbit anti-mouse antibodies was followed by enhanced chemiluminescence using Lumi-GLO reagents (Kirkegoard and Perry, Gaithensburg, MA). The lamin A/C signals were quantified by densitometry and normalized according to lamin B1 signals.
Statistical analysis. All results are expressed as means Ϯ SE of three replicate determinations, and statistical comparisons are based on one-way ANOVA or Student's t-tests. A P value of Ͻ0.05 was considered significant and Ն0.05 was considered nonsignificant (NS).
RESULTS
The young (n ϭ 5) and old (n ϭ 5) C57BL/6J mice were representative of the litter and did not have identifiable diseases. Dissection of the murine hearts revealed that the mean mass of the isolated hearts was 189 Ϯ 15 mg in old mice and 167 Ϯ 15 mg in young mice (P Ͻ 0.05). Microscopic inspection of the hematoxylin and eosin-stained sections did not reveal any gross pathology in the cardiac tissues (Fig. 1, A and  B) . The number of cardiomyocytes per HPF was inferior in old mice compared with young mice (40 -62 vs. 65-80 cells/HPF, P Ͻ 0.05), whereas the cell size was similar (108 vs. 110 m, P ϭ NS).
Echocardiographic results are shown in Immunohistochemical analyses showed that the expression of lamin A/C but not lamin B1 was reduced in cardiomyocyte nuclei of old mice (Fig. 1, C-F) . The proportion of nuclei positively stained for lamin A/C was 9 Ϯ 6% in old mice and 62 Ϯ 16% in young mice (P Ͻ 0.001). In contrast, the proportion of nuclei positively stained for lamin B1 control remained constant (90 Ϯ 6% in old mice and 96 Ϯ 4% in young mice, P ϭ NS). Immunofluorescence analyses also showed that the expression of lamin A/C was reduced in cardiomyocyte nuclei of old mice (Fig. 2, A-D) .
In addition to quantitative changes in lamin A/C expression, qualitative changes in lamin A/C distribution were observed. The distribution of lamin A/C was homogeneous throughout the nuclei in young mice, whereas it was scattered toward the periphery and perinuclear with minimal contact between staining sites in old mice (Fig. 2, E and F) .
Western blot analyses confirmed and quantified the reduction in lamin A/C expression in cardiomyocyte nuclear extracts of old mice (Fig. 3) . The ratio of lamin A/C to B1 as measured by densitometry was 0.6 in old mice and 1.2 in young mice (P Ͻ 0.01).
Finally, changes in lamin A/C expression were observed in other heart cells. Specifically, immunohistochemical analyses suggested that the expression of lamin A/C but not B1 was reduced in vascular endothelial cell nuclei of old mice compared with young mice (Fig. 4) .
DISCUSSION
Our study is the first to show that normal aging is associated with a reduced expression of lamin A/C in cardiomyocytes. Moreover, we found that normal aging is associated with a scattered perinuclear distribution of lamin A/C and may be associated with a reduced expression of lamin A/C in vascular endothelial cells. Thus, age-related changes in lamin A/C expression and distribution denote a novel aging mechanism previously described in the dermatologic and osteoarticular systems (9, 30) and are now discovered in the cardiovascular system.
Our finding of reduced myocardial lamin A/C expression with aging is preceded by the well-documented finding of reduced myocardial lamin A/C expression with inherited LMNA mutations (1, 39) . LMNA mutations are among the most common causes of familial autosomal-dominant cardiomyopathy (18) . Individuals with these mutations often have heart failure with increased LV wall thickness (37) . Up to 88% of affected individuals have electrophysiological disturbances such as sick sinus syndrome, atrioventricular block, and atrial fibrillation or flutter (10, 16) . This constellation of findings shares several features with the physiopathological changes seen in the aging heart (22, 23) . We speculate that LMNArelated familial cardiomyopathy and age-related senile cardiomyopathy may represent two entities in a spectrum of lamin A/C-deficient heart disease.
The newly discovered association of aging and myocardial lamin A/C expression is a fundamental first step in lamincardiology research. It opens the door for further characterization of the age-related changes in myocardial lamin A/C expression and distribution. More importantly, it opens the door for mechanistic research to test whether there exists a causal link between the observed decline in lamin A/C and the parallel abnormalities in myocardial structure and function. One potential link between lamin A/C and aging hearts may be that both are epitomized by an impaired cellular and nuclear response to stressors. The structural model of age-related changes in lamin A/C suggests that loss of lamin function causes nuclear fragility which leads to permanent damage or death in the face of mechanical or environmental stressors (33) . Similarly, age-related changes in the heart are described as a state of fragility or reduced adaptation to acute and chronic stressors such as exercise or myocardial ischemia (11, 13-15, 21, 27, 29) .
In agreement with prior studies conducted in animal models and in human subjects (2, 3, 6, 31, 40) , old mice demonstrated increased LV wall thickness with preserved cavity size resulting in increased relative wall thickness (concentric remodeling) and mass. Systolic function was slightly, yet significantly, reduced as previously demonstrated by Yang et al. (40) . Although diastolic function was difficult to assess given the rapid heart rates of our mice under physiological conditions (mean, 548 -563) and the challenge of transducer positioning for reliable parallel mitral inflow, our finding of concentric hypertrophy is consistent with the finding of a relaxation abnormality in senescent mice demonstrated by Taffet et al. (36) . We do not intend for the echocardiographic data to be causally explanatory; however, we believe that these data add an important dimension to our study by showing that the morphological and functional correlation of our histopathological findings is consistent with the expected changes of myocardial aging. Clinically, lamin A/C has the potential to be a prognostic marker and a therapeutic target. Among 15 patients with nonischemic cardiomyopathy requiring LV assist device support, lamin A/C expression over time was a strong predictor of myocardial recovery leading to the explantation of the device (4). In presymptomatic LMNA mutation carriers, lamin A/C expression may be used as a screening tool to identify high-risk subjects who may benefit from more aggressive therapy (28) . Therapeutic agents such as farnesylation modulators have been shown to prevent or reverse some of the nuclear defects in Hutchinson-Gilford progeria syndrome (7, 8, 12, 25, 38) . These agents modulate posttranslational conversion of precursor prelamin A to the active lamin A, correcting the nuclear defect associated with lamin A depletion or prelamin A accumulation. To our knowledge, the effect of farnesylation modulators on normal aging or on the cardiovascular system has not been evaluated.
In conclusion, the expression of lamin A/C is substantially reduced and the distribution is scattered peripherally in nuclei of cardiomyocytes isolated from a validated mouse model of aging. Further research in this field may attempt to clarify the causal link between lamin A/C and aging hearts and to explore the value of farnesylation modulators as novel therapeutic agents to counter the potentially negative effects of lamin A/C depletion on the heart.
